Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Tax Provisions (2016 - 2023)

Wave Life Sciences (WVE) has disclosed Tax Provisions for 8 consecutive years, with $23000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Tax Provisions fell 96.62% year-over-year to $23000.0, compared with a TTM value of $23000.0 through Sep 2024, up 475.0%, and an annual FY2023 reading of -$677000.0, down 199.41% over the prior year.
  • Tax Provisions was $23000.0 for Q4 2023 at Wave Life Sciences, up from -$677000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $681000.0 in Q4 2022 and bottomed at -$841000.0 in Q4 2020.
  • Average Tax Provisions over 4 years is -$203600.0, with a median of -$204000.0 recorded in 2021.
  • The sharpest move saw Tax Provisions skyrocketed 433.82% in 2022, then tumbled 96.62% in 2023.
  • Year by year, Tax Provisions stood at -$841000.0 in 2020, then skyrocketed by 75.74% to -$204000.0 in 2021, then surged by 433.82% to $681000.0 in 2022, then crashed by 96.62% to $23000.0 in 2023.
  • Business Quant data shows Tax Provisions for WVE at $23000.0 in Q4 2023, -$677000.0 in Q3 2023, and $681000.0 in Q4 2022.